Exane Derivatives’s Marathon Oil Corporation MRO Stock Holding History

Exane Derivatives’s Portfolio MRO Stock Details MRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$19.4K	Sell	862 -26,992	-97%	-$722K	0.01%	365
2022 Q1	$699K	Sell	27,854 -3,739	-12%	-$80.3K	0.2%	135
2021 Q4	$519K	Buy	+31,593	New	+$508K	0.13%	170
2018 Q4	–	Sell	-1	Closed	-$23	–	752
2018 Q3	$23	Sell	1 -910	-100%	-$19K	﹤0.01%	673
2018 Q2	$19K	Sell	911 -16,922	-95%	-$334K	﹤0.01%	434
2018 Q1	$273K	Buy	17,833 +2,246	+14%	+$37.3K	0.05%	219
2017 Q4	$264K	Buy	15,587 +365	+2%	+$5.42K	0.05%	215
2017 Q3	$206K	Buy	15,222 +1,427	+10%	+$16.9K	0.04%	197
2017 Q2	$163K	Buy	13,795 +3,888	+39%	+$54.4K	0.04%	214
2017 Q1	$157K	Buy	9,907 +2,775	+39%	+$45.5K	0.04%	202
2016 Q4	$123K	Sell	7,132 -882	-11%	-$14.2K	0.02%	233
2016 Q3	$127K	Buy	8,014 +571	+8%	+$8.48K	0.02%	224
2016 Q2	$112K	Buy	+7,443	New	+$98.4K	0.02%	235
2015 Q3	–	Sell	-6,887	Closed	-$183K	–	575
2015 Q2	$183K	Buy	+6,887	New	+$194K	0.02%	213

Other funds holding MRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Exane Derivatives's MRO Position: Q2 2022 in Review

Exane Derivatives reduced its Marathon Oil Corporation (MRO) stake by 97% in Q2 2022, selling an estimated $722K and leaving 862 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #365.

Exane Derivatives first reported a position in MRO in Q2 2015 and has held it in 14 quarters since. The position peaked at $699K in Q1 2022. 749 funds tracked by Wall St. Rank hold MRO as of Q2 2022.

Exane Derivatives held 862 shares of Marathon Oil Corporation worth $19.4K as of Q2 2022.
Exane Derivatives sold 26,992 Marathon Oil Corporation shares in Q2 2022, an estimated $722K.
Marathon Oil Corporation made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #365 holding.
Exane Derivatives first reported a position in Marathon Oil Corporation in Q2 2015 and has held it in 14 quarters since.
Exane Derivatives's Marathon Oil Corporation position peaked at $699K in Q1 2022.
749 funds tracked by Wall St. Rank held Marathon Oil Corporation as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.